Sterility & Microbiology
Sterile and aseptically produced products demand the strictest contamination controls in the industry. This pillar covers the EU GMP Annex 1 contamination control strategy, aseptic processing and media fills, environmental monitoring program design, and the microbiological data that underpins sterility assurance.
14 articlesBioburden and Bacterial Endotoxin Testing: USP <61>/<62> and <85> LAL Methods
How routine microbial QC supports parenteral release: total counts and specified organisms by USP <61>/<62>, bacterial endotoxin testing by USP <85> and the recombinant reagent chapter <86>, endotoxin limit and MVD calculations, in-process bioburden limits, Low Endotoxin Recovery, and choosing a pyrogen testing strategy.
Cleanroom Classification and Qualification: ISO 14644, Grade A-D, and Recovery Testing
How cleanrooms are classified and qualified for sterile manufacturing: ISO 14644 particle counting, EU GMP Grade A-D, at-rest vs in-operation states, smoke studies, recovery testing, pressure cascade, and HEPA integrity.
Disinfectant and Sporicidal Efficacy Qualification
How to design and defend a disinfectant and sporicidal efficacy program: coupon and carrier studies, log-reduction acceptance, contact time, real surface materials, in-use versus laboratory efficacy, rotation rationale, sporicidal frequency, and neutralization controls.
Designing an Environmental Monitoring Program for Sterile Manufacturing
How to build and defend an environmental monitoring program for aseptic processing, viable and non-viable sampling, alert and action levels, risk-based site selection, trending, excursion investigation, and the data-integrity gaps inspectors hunt for.
Microbial Identification, Excursions, and the EM Data Trend
How to identify recovered organisms, investigate environmental monitoring excursions, set alert and action limits, trend EM data, and handle objectionable organisms in a GMP facility.
Sterility Testing: USP <71>, Membrane Filtration, and Method Suitability
How the compendial sterility test works under USP <71>: membrane filtration versus direct inoculation, bacteriostasis and fungistasis (method suitability), incubation, and how to invalidate a false positive.
Visual Inspection and Particulate Control for Injectables: USP <790> and <788>
How 100% visual inspection, AQL sampling, inspector qualification, and sub-visible particulate testing work for sterile injectables, with the regulatory basis and concrete procedures to run the program.
EU GMP Annex 1 and the Contamination Control Strategy
How the 2022 Annex 1 revision elevated the Contamination Control Strategy from implicit good practice to a documented, holistic requirement, what it must contain and how inspectors test it.
Aseptic Processing and Aseptic Process Simulations (Media Fills)
A working reference on how sterile drug products are made by aseptic processing and how media fills qualify the line: cleanroom grades, gowning, intervention design, acceptance criteria, and what inspectors check.
Container Closure Integrity Testing: Deterministic Methods and Annex 1 Expectations
How CCIT works in practice: deterministic methods like vacuum decay, HVLD and headspace analysis, the USP <1207> lifecycle approach, method validation, and what inspectors expect under EU Annex 1.
Depyrogenation and Dry Heat Sterilization: Endotoxin Challenge and Validation
How to validate dry heat depyrogenation tunnels and ovens against a 3-log endotoxin reduction challenge, including endotoxin indicators, load mapping, and the acceptance criteria inspectors expect.
Sterilization Validation: Moist Heat, Overkill vs Bioburden, F0, and Biological Indicators
How to develop and validate a moist heat (steam) sterilization cycle: overkill and bioburden approaches, F0 and lethality math, D-value and z-value, biological indicators, the half-cycle method, and heat penetration and distribution studies.
Sterilizing-Grade Filtration Validation
How to validate a 0.2 micron sterilizing-grade filter for a drug product, covering bacterial retention, chemical compatibility, extractables and leachables, adsorption, integrity test correlation, PUPSIT, and post-use release testing.
Pharmaceutical Water System Validation: USP <1231>, WFI, and the Three-Phase Qualification
How to qualify and validate a pharmaceutical water system: generation of Purified Water and Water for Injection, distribution loop design and sanitization, the three-phase qualification, and the conductivity, TOC, and microbial monitoring program.